GALT
NASDAQ · Biotechnology
Galectin Therapeutics Inc
$3.44
-0.09 (-2.55%)
Next Earnings Report
EPS Surprise History
Earnings Summary
Beats (Last 2)
1/2
Avg Surprise
-4.6%
Latest EPS
$-0.08
History
2 quarters
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| May 15, 2026 | Q2 FY2026 | $-0.06 | $-0.08 | -$0.02 | -30.7% | Miss |
| Mar 31, 2026 | Q1 FY2026 | $-0.10 | $-0.08 | +$0.02 | +21.6% | Beat |
| Mar 26, 2026 | Q1 FY2026 | $-0.10 | — | — | — | — |